NCT03584919

Comparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans

Comparison of Doxycycline and Cefuroxime Axetil in Patients With Erythema Migrans

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 509 (planned)
• Sponsor: University Medical Centre Ljubljana · Academic / Other
• Sex: All
• Age: 15 Years
• Healthy volunteers: Accepted

Summary

A European, prospective clinical trial in which doxycycline and cefuroxime axetil were compared in the treatment of adult patients with erythema migrans included a control group to address this question. Evaluations of patients were conducted at baseline, 14 days and 2, 6, and 12 months after enrollment. Control subjects were evaluated at baseline and at 6 and 12 months. Subjective complaints that newly developed or intensified since the onset of erythema migrans or since the date of enrollment for controls were referred to as "new or increased symptoms"(NOIS).

Conditions

• Erythema Chronicum Migrans

Interventions

Type	Name	Description
DRUG	doxycycline	patients received oral doxycycline 100 milgrams bid for 15 days
DRUG	Cefuroxime Axetil 500Mg Tab	patients received cefuroxime axetil 500 milgrams bid for 15 days
OTHER	control subjects	no intervention

Timeline

• Start date: 2006-06-01
• Primary completion: 2007-09-30
• Completion: 2007-09-30
• First posted: 2018-07-12
• Last updated: 2018-07-12